Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India

[1]  D. Daniel,et al.  Red cell alloimmunization among antenatal women attending a tertiary care hospital in south India , 2013, The Indian journal of medical research.

[2]  M. Pujani,et al.  The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. , 2011, Blood transfusion = Trasfusione del sangue.

[3]  D. Filbey,et al.  Alloimmunization in pregnancy during the years 1992–2005 in the central west region of Sweden , 2008, Acta obstetricia et gynecologica Scandinavica.

[4]  G. Bonsel,et al.  Effect of screening for red cell antibodies, other than anti‐D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands , 2008, Transfusion.

[5]  C. Lam,et al.  Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy – a review of cases from 1997 to 2001 , 2003, Transfusion medicine.

[6]  S. Lurie,et al.  Is antibody screening in Rh (D)-positive pregnant women necessary? , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  K. Morris,et al.  The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland. , 2001, The Ulster medical journal.

[8]  H. Oosterbaan,et al.  [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch]. , 1999, Nederlands tijdschrift voor geneeskunde.

[9]  A. de Man,et al.  [Irregular blood group antibodies during pregnancy: screening is mandatory]. , 1999, Nederlands tijdschrift voor geneeskunde.

[10]  A. Hadley.  A Comparison of in Vitro Tests for predicting the Severity of Haemolytic Disease of the Fetus and Newborn , 1998, Vox sanguinis.

[11]  I. Bromilow,et al.  Consequences for fetus and neonate of maternal red cell allo-immunisation , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[12]  G. Daniels.  Human Blood Groups , 1995 .

[13]  U. Hanson,et al.  The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: , 1995, Acta obstetricia et gynecologica Scandinavica.

[14]  L. Silberstein,et al.  Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient , 1990, Transfusion.

[15]  B. Sibai,et al.  Irregular Antibodies: An Assessment of Routine Prenatal Screening , 1983, Obstetrics and gynecology.

[16]  S. Lewis,et al.  British Committee for Standards in Haematology , 1969 .

[17]  P. Mollison,et al.  Progress in Hematology , 1957 .

[18]  J. Christenson,et al.  Red Blood Cell Alloimmunization among Saudi Pregnant Women in the Central Province of Saudi Arabia 116 , 2008 .

[19]  D. Harmening.  Modern Blood Banking And Transfusion Practices , 1983 .